Study evaluating ease of use, preference and satisfaction of two different Fluticason/salmeterol inhalers in asthma or COPD patients

Phase 4

Completed

• Conditions: Asthma; COPD; 10006436

• Registration Number: NL-OMON35747
• Lead Sponsor: Medisch Spectrum Twente

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 110

Inclusion Criteria

1. Age > 40 with stable COPD or asthma
2. Patients naïve to the study inhalers, Accuhaler/Diskus and Elpenhaler for at least 1 year
3. Patients agreeing on participating and signing the Informed Consent Form

Exclusion Criteria

1. Patients currently participating in another randomised clinical trial
2. Patients with body malformations or diseases affecting coordination and/or motor system
3. Patients unable to read product package instructions and answer patient reported questionnaires

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The percentage of COPD and asthma patients correctly (all critical items<br /><br>correct) using the Accuhaler/Diskus vs Elpenhaler inhaler devices after reading<br /><br>the package insert</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To assess patient*s overall satisfaction with each device.<br /><br>To assess the number of instructions needed for correct use of each device<br /><br>To assess the patient*s overall preference for a device</p><br>